LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis | MicrobiomeTrials← Back to trialsNCT07450027
LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis
CompletedOBSERVATIONAL
Trial Details
Start: 2025-09-01Est. Completion: 2026-04-01
Enrollment target: 111 participants Locations- Elazığ Mental Health and Diseases Hospital, Elâzığ, Elâzığ, Turkey (Türkiye)
Other microbiome trials you might be interested in
Opioid Use DisorderDual DiagnosisHousing ProblemsMental Disorder in AdolescenceRisk BehaviorHomelessness
Homelessness severely affects health and well-being and is particularly negative for youth. Between 70-95% of youth expe…
Columbus, United StatesEst. completion Dec 1, 2028
Methamphetamine Use DisorderMethamphetamine Induced Psychosis
This prospective cohort study aims to examine and compare electrocardiogram (ECG) parameters in subjects diagnosed with …
Elâzığ, Turkey (Türkiye)Est. completion Nov 2, 2026